Humankind Investments LLC Acquires 194 Shares of Tenet Healthcare Co. (NYSE:THC)

Humankind Investments LLC grew its stake in Tenet Healthcare Co. (NYSE:THC) by 6.5% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 3,166 shares of the company’s stock after acquiring an additional 194 shares during the quarter. Humankind Investments LLC’s holdings in Tenet Healthcare were worth $400,000 at the end of the most recent quarter.

A number of other hedge funds have also recently made changes to their positions in the stock. Colonial Trust Co SC lifted its position in shares of Tenet Healthcare by 85.7% during the fourth quarter. Colonial Trust Co SC now owns 247 shares of the company’s stock valued at $31,000 after buying an additional 114 shares during the last quarter. GeoWealth Management LLC lifted its position in Tenet Healthcare by 39.8% during the fourth quarter. GeoWealth Management LLC now owns 295 shares of the company’s stock valued at $37,000 after acquiring an additional 84 shares during the last quarter. WR Wealth Planners LLC grew its holdings in Tenet Healthcare by 2,836.4% in the fourth quarter. WR Wealth Planners LLC now owns 323 shares of the company’s stock worth $41,000 after purchasing an additional 312 shares during the last quarter. Smartleaf Asset Management LLC increased its position in shares of Tenet Healthcare by 30.5% during the fourth quarter. Smartleaf Asset Management LLC now owns 471 shares of the company’s stock worth $59,000 after purchasing an additional 110 shares in the last quarter. Finally, Kestra Investment Management LLC acquired a new stake in shares of Tenet Healthcare in the 4th quarter worth $60,000. 95.44% of the stock is currently owned by hedge funds and other institutional investors.

Tenet Healthcare Stock Down 0.2 %

THC opened at $148.80 on Friday. The company has a fifty day moving average of $129.38 and a two-hundred day moving average of $135.94. The company has a debt-to-equity ratio of 2.25, a quick ratio of 1.70 and a current ratio of 1.78. Tenet Healthcare Co. has a fifty-two week low of $109.82 and a fifty-two week high of $171.20. The stock has a market capitalization of $13.82 billion, a price-to-earnings ratio of 4.62, a PEG ratio of 1.02 and a beta of 1.63.

Tenet Healthcare (NYSE:THC) last issued its quarterly earnings results on Tuesday, April 29th. The company reported $4.36 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $3.11 by $1.25. The company had revenue of $5.22 billion for the quarter, compared to the consensus estimate of $5.15 billion. Tenet Healthcare had a return on equity of 21.88% and a net margin of 15.48%. Tenet Healthcare’s revenue for the quarter was down 2.5% on a year-over-year basis. During the same quarter in the prior year, the business posted $3.22 earnings per share. On average, research analysts expect that Tenet Healthcare Co. will post 12.24 earnings per share for the current year.

Insider Transactions at Tenet Healthcare

In other Tenet Healthcare news, Director J Robert Kerrey sold 9,525 shares of the business’s stock in a transaction that occurred on Tuesday, March 11th. The stock was sold at an average price of $125.43, for a total transaction of $1,194,720.75. Following the completion of the sale, the director now directly owns 27,378 shares in the company, valued at approximately $3,434,022.54. The trade was a 25.81 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Corporate insiders own 0.81% of the company’s stock.

Analyst Upgrades and Downgrades

A number of research firms have commented on THC. Barclays increased their price target on Tenet Healthcare from $161.00 to $171.00 and gave the company an “overweight” rating in a research note on Wednesday, April 30th. The Goldman Sachs Group boosted their target price on shares of Tenet Healthcare from $134.00 to $154.00 and gave the stock a “neutral” rating in a research report on Monday, May 5th. Robert W. Baird reiterated a “neutral” rating and set a $137.00 price objective (down from $153.00) on shares of Tenet Healthcare in a research note on Tuesday, April 15th. TD Cowen initiated coverage on Tenet Healthcare in a research report on Wednesday, February 26th. They issued a “buy” rating and a $175.00 target price on the stock. Finally, Cantor Fitzgerald reaffirmed an “overweight” rating and set a $177.00 price target on shares of Tenet Healthcare in a research report on Thursday, February 13th. Four equities research analysts have rated the stock with a hold rating and fourteen have issued a buy rating to the company’s stock. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $173.69.

Tenet Healthcare Profile

Tenet Healthcare Corporation operates as a diversified healthcare services company in the United States. The company operates through two segments: Hospital Operations and Services, and Ambulatory Care. Its general hospitals offer acute care services, operating and recovery rooms, radiology and respiratory therapy services, clinical laboratories, and pharmacies.